SU2C Phase Ib study of the PI3K-alpha inhibitor BYL719 (alpelisib) with letrozole in ER+/HER2-metastatic breast cancer Meeting Abstract
| Authors: | Mayer, I. A.; Abramson, V.; Balko, J.; Sanders, M.; Juric, D.; Solit, D.; Li, Y. S.; Cantley, L.; Winer, E.; Arteaga, C. |
| Abstract Title: | SU2C Phase Ib study of the PI3K-alpha inhibitor BYL719 (alpelisib) with letrozole in ER+/HER2-metastatic breast cancer |
| Meeting Title: | 106th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 75 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 Apr 18-22 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-08-01 |
| Language: | English |
| ACCESSION: | WOS:000371597100066 |
| DOI: | 10.1158/1538-7445.am2015-ct232 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT232 -- 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 18-22, 2015 -- Philadelphia, PA -- Source: Wos |
